SHIP‐1, a target of miR‐155, regulates endothelial cell responses in lung fibrosis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SHIP‐1, a target of miR‐155, regulates endothelial cell responses in lung fibrosis
Authors
Keywords
-
Journal
FASEB JOURNAL
Volume 34, Issue 2, Pages 2011-2023
Publisher
Wiley
Online
2019-12-13
DOI
10.1096/fj.201902063r
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Endothelial Cells Tissue-Specific Origins Affects Their Responsiveness to TGF-β2 during Endothelial-to-Mesenchymal Transition
- (2019) Fernanda Ursoli Ferreira et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Fibroblast senescence in the pathology of idiopathic pulmonary fibrosis
- (2018) David W Waters et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Targeting Hypoxia-Inducible Factor-1α/Pyruvate Dehydrogenase Kinase 1 Axis by Dichloroacetate Suppresses Bleomycin-induced Pulmonary Fibrosis
- (2018) Justin Goodwin et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- The role of microRNAs in chronic respiratory disease: recent insights
- (2018) Lindsay R. Stolzenburg et al. BIOLOGICAL CHEMISTRY
- NLRP3 Inflammasome Activation Contributes to Mechanical Stretch–Induced Endothelial-Mesenchymal Transition and Pulmonary Fibrosis
- (2018) Zhou Lv et al. CRITICAL CARE MEDICINE
- Expression of microRNA-155 in inflammatory cells modulates liver injury
- (2018) Delia Blaya et al. HEPATOLOGY
- Granulocyte-CSF links destructive inflammation and comorbidities in obstructive lung disease
- (2018) Evelyn Tsantikos et al. JOURNAL OF CLINICAL INVESTIGATION
- SHIP1 Deficiency in Inflammatory Bowel Disease Is Associated With Severe Crohn’s Disease and Peripheral T Cell Reduction
- (2018) Sandra Fernandes et al. Frontiers in Immunology
- Regulation of Hematopoietic Cell Development and Function Through Phosphoinositides
- (2018) Mila Elich et al. Frontiers in Immunology
- Endothelial to Mesenchymal Transition Represents a Key Link in the Interaction between Inflammation and Endothelial Dysfunction
- (2018) Jin Gu Cho et al. Frontiers in Immunology
- The role of microRNA-155/liver X receptor pathway in experimental and idiopathic pulmonary fibrosis
- (2017) Mariola Kurowska-Stolarska et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Potential role of the Jagged1/Notch1 signaling pathway in the endothelial-myofibroblast transition during BLM-induced pulmonary fibrosis
- (2017) Qian Yin et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Targeting the vascular and perivascular niches as a regenerative therapy for lung and liver fibrosis
- (2017) Zhongwei Cao et al. Science Translational Medicine
- Endothelial Microparticles are Associated to Pathogenesis of Idiopathic Pulmonary Fibrosis
- (2017) Nour C. Bacha et al. Stem Cell Reviews and Reports
- Endothelial Microparticles are Associated to Pathogenesis of Idiopathic Pulmonary Fibrosis
- (2017) Nour C. Bacha et al. Stem Cell Reviews and Reports
- Macrophage micro-RNA-155 promotes lipopolysaccharide-induced acute lung injury in mice and rats
- (2016) Wen Wang et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Regulation of PtdIns(3,4,5)P3/Akt signalling by inositol polyphosphate 5-phosphatases
- (2016) M. J. Eramo et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Nitro-oleic acid inhibits vascular endothelial inflammatory responses and the endothelial-mesenchymal transition
- (2016) Gabriela Ambrozova et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers
- (2016) Katrien Van Roosbroeck et al. CLINICAL CANCER RESEARCH
- In vivo inhibition of miR-155 significantly alters post-stroke inflammatory response
- (2016) Juan Carlos Pena-Philippides et al. Journal of Neuroinflammation
- Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of Systemic Sclerosis-associated pulmonary fibrosis and pulmonary arterial hypertension. Myth or reality?
- (2016) Sergio A. Jimenez et al. MATRIX BIOLOGY
- Endothelial to mesenchymal transition is common in atherosclerotic lesions and is associated with plaque instability
- (2016) Solene M. Evrard et al. Nature Communications
- MicroRNAs in idiopathic pulmonary fibrosis: involvement in pathogenesis and potential use in diagnosis and therapeutics
- (2016) Huimin Li et al. Acta Pharmaceutica Sinica B
- Endothelial to Mesenchymal Transition (EndoMT) in the Pathogenesis of Human Fibrotic Diseases
- (2016) Sonsoles Piera-Velazquez et al. Journal of Clinical Medicine
- Myofibroblasts in proliferative diabetic retinopathy can originate from infiltrating fibrocytes and through endothelial-to-mesenchymal transition (EndoMT)
- (2015) Ahmed M. Abu El-Asrar et al. EXPERIMENTAL EYE RESEARCH
- MicroRNA-155 Deficiency Attenuates Liver Steatosis and Fibrosis without Reducing Inflammation in a Mouse Model of Steatohepatitis
- (2015) Timea Csak et al. PLoS One
- SHIP-1 deficiency in the myeloid compartment is insufficient to induce myeloid expansion or chronic inflammation
- (2014) M J Maxwell et al. GENES AND IMMUNITY
- MicroRNAs in B-cell lymphomas: how a complex biology gets more complex
- (2014) K Musilova et al. LEUKEMIA
- Distinct Macrophage Subpopulations Characterize Acute Infection and Chronic Inflammatory Lung Disease
- (2012) M. Duan et al. JOURNAL OF IMMUNOLOGY
- Genetic Segregation of Inflammatory Lung Disease and Autoimmune Disease Severity in SHIP-1-/- Mice
- (2011) M. J. Maxwell et al. JOURNAL OF IMMUNOLOGY
- MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis
- (2011) M. Kurowska-Stolarska et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started